Y-X Zeng

1.1k total citations
10 papers, 884 citations indexed

About

Y-X Zeng is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Y-X Zeng has authored 10 papers receiving a total of 884 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Epidemiology. Recurrent topics in Y-X Zeng's work include Epigenetics and DNA Methylation (3 papers), Cancer-related Molecular Pathways (3 papers) and RNA modifications and cancer (2 papers). Y-X Zeng is often cited by papers focused on Epigenetics and DNA Methylation (3 papers), Cancer-related Molecular Pathways (3 papers) and RNA modifications and cancer (2 papers). Y-X Zeng collaborates with scholars based in China, Hong Kong and United States. Y-X Zeng's co-authors include Rong Deng, Jun Tang, Dandan Li, Yang Shen, Qinqin Liu, Dan Xie, Yiji Liao, Mei-Yi Lin, Xin‐Yuan Guan and Wei‐Guo Zhu and has published in prestigious journals such as Oncogene and Journal of Clinical Microbiology.

In The Last Decade

Y-X Zeng

10 papers receiving 873 citations

Peers

Countries citing papers authored by Y-X Zeng

Since Specialization

Citations

This map shows the geographic impact of Y-X Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y-X Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y-X Zeng more than expected).

Fields of papers citing papers by Y-X Zeng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y-X Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y-X Zeng. The network helps show where Y-X Zeng may publish in the future.

Co-authorship network of co-authors of Y-X Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Y-X Zeng. A scholar is included among the top collaborators of Y-X Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y-X Zeng. Y-X Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Overexpression of maelstrom promotes bladder urothelial carcinoma cell aggressiveness by epigenetically downregulating MTSS1 through DNMT3B 2016 ·Oncogene ·Xiaodong Li, JX Zhang, (unknown), (unknown), (unknown), (unknown), (unknown), Wen‐Hua Chen, (unknown), (unknown), (unknown), Y-X Zeng, Xin‐Yuan Guan, Zhiwen Liu, Dan Xie	31
2	Foxo3a transcription factor is a negative regulator of Skp2 and Skp2 SCF complex 2012 ·Oncogene ·Jueheng Wu, Seong‐Wook Lee, Xian Zhang, Fei Han, (unknown), Xiaoling Yuan, (unknown), Yongsoo Jeong, (unknown), Yuan Gao, Y-X Zeng, (unknown)	33
3	EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin 2011 ·Oncogene ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yiji Liao, Fei-Meng Zheng, Wei‐Guo Zhu, Tsung‐Hao Liu, (unknown), Xin‐Yuan Guan, Mei-Yi Lin, Mu‐Sheng Zeng, Y-X Zeng, (unknown), Dan Xie	176
4	hSSB1 binds and protects p21 from ubiquitin-mediated degradation and positively correlates with p21 in human hepatocellular carcinomas 2011 ·Oncogene ·Shihe Xu, Zizhen Feng, (unknown), (unknown), Yi Sang, Hongde Xu, Xiaobin Lv, Kunpeng Hu, (unknown), (unknown), Li‐Mei Chen, Ming Liu, J-P Yun, Y-X Zeng, Tiebang Kang	45
5	Anthracyclines disrupt telomere maintenance by telomerase through inducing PinX1 ubiquitination and degradation 2011 ·Oncogene ·(unknown), Dong Qian, (unknown), Rui Jin, (unknown), (unknown), (unknown), Yiji Liao, (unknown), (unknown), (unknown), Y-X Zeng, Mei-Yi Lin, (unknown), Dan Xie, (unknown)	44
6	PKB/Akt promotes DSB repair in cancer cells through upregulating Mre11 expression following ionizing radiation 2010 ·Oncogene ·Rong Deng, Jun Tang, (unknown), (unknown), (unknown), (unknown), Dandan Li, (unknown), Y-X Zeng, (unknown)	71
7	The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells 2008 ·Oncogene ·Dandan Li, (unknown), Rong Deng, Jun Tang, Yang Shen, (unknown), (unknown), (unknown), (unknown), Qinqin Liu, (unknown), Y-X Zeng, (unknown)	231
8	Acetylcholinesterase expression mediated by c-Jun-NH2-terminal kinase pathway during anticancer drug-induced apoptosis 2006 ·Oncogene ·Rong Deng, (unknown), Zhenpeng Guan, (unknown), (unknown), (unknown), (unknown), (unknown), Wenlin Huang, (unknown), Yifan Han, Y-X Zeng, (unknown)	57
9	Single-Assay Combination of Epstein-Barr Virus (EBV) EBNA1- and Viral Capsid Antigen-p18-Derived Synthetic Peptides for Measuring Anti-EBV Immunoglobulin G (IgG) and IgA Antibody Levels in Sera from Nasopharyngeal Carcinoma Patients: Options for Field Screening 2006 ·Journal of Clinical Microbiology ·Jajah Fachiroh, Dewi Kartikawati Paramita, Bambang Hariwiyanto, (unknown), (unknown), Sagung Rai Indrasari, (unknown), Y-X Zeng, Tabitha Schouten, (unknown), Jaap M. Middeldorp	102
10	Senescence and telomere shortening induced by novel potent G-quadruplex interactive agents, quindoline derivatives, in human cancer cell lines 2005 ·Oncogene ·(unknown), (unknown), (unknown), Rong Deng, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Y-X Zeng	94

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact